treat recurrent UTI with less anti-biotics
empower your patients with innate immune activation
ImmunoRing uses safe extremely low frequency electromagnetic fields to activate innate immune responses at the first sign of UTI symptoms. It is clinically designed to accelerate natural defense mechanisms—reducing reliance on antibiotics and improving patient outcomes.
Controlled electromagnetic field (EMF) exposure modulates immune cell activity. By targeting early-stage immune signaling, the device gives the immune response with a a 3-day head start against urinary tract infections—without pharmacological intervention.
a scientifically proven instant protection Shield
In bacterial and viral infections there is a substantial lag period between infection and immune-system activation. In fact, many bacterial infections play an active role in keeping the immune system asleep while proliferating explosively.
Low-frequency electromagnetic fields (LF-EMF) have been shown to play a significant role in modulating immune responses, particularly through the activation of neutrophils. Studies demonstrate that LF-EMF exposure can counteract immune delays caused by neutrophil dysregulation, reducing the spread of pathogens.
Evidence for this benefit has been published in human and animal, in vivo and ex-vivo studies, where LF-EMF signals activate human neutrophils and reduce tissue damage and mortality through enhanced antimicrobial function.
The potential of LF-EMF to mitigate recurrent infections such as urinary tract infections (UTIs), by activating neutrophils, presents a groundbreaking approach to infection mitigation. ImmunoRing has transformed these scientific insights into a single, practical device for your patients.
Our journey and where we are today
ImmunoRing R&D undergoes rigorous validation to ensure it meets the highest standards in effectiveness and safety. Our team has a multitude of publications on its name, validating our technology during more over a decade. But let’s be honest: we still have some obstacles to overcome. We are currently in the proces of getting METC approval for our second human clinical study for mitigating rUTI. Afterwards, we still need to go through CE compliance. The aimed result: a device that delivers proven technical capability and clinical reliability.
-
We've demonstrated that electromagnetic fields can enhance immune function in diverse animal models.
Our comprehensive research program has revealed consistent immune-stimulating effects of low-frequency electromagnetic fields (EMFs) across multiple species and experimental models.
Our Key Discoveries
In fish and chickens, we showed that weak LF EMF exposure stimulates immune responses, providing early evidence of electromagnetic field effects on immunity (Environmentalist, 2007). Building on this, we demonstrated that EMF exposure exerts an antagonistic effect against coccidiosis infection in broiler chickens, offering potential therapeutic applications in poultry health (Poultry Science, 2007).
Our work in mammalian models further confirmed these findings: short-term ELF EMF exposure increases circulating leukocyte numbers and modulates HPA-axis signaling in mice (Bioelectromagnetics, 2016), demonstrating systemic immune activation.
The Significance
Across fish, birds, and mammals, our studies consistently show that electromagnetic fields can actively modulate immune function. This cross-species validation strengthens the scientific foundation for understanding EMF-immune system interactions.
Why It Matters
Our research opens new possibilities for EMF-based immune modulation therapies and provides critical insights into the biological mechanisms underlying electromagnetic field effects on living organisms.
-
Our Groundbreaking Study: Electromagnetic Fields Enhance Immune Defense
We've uncovered a fascinating connection between electromagnetic fields and immune function.
In our pioneering research published in the Journal of Innate Immunity (2015), we demonstrated that low-frequency electromagnetic field (LF EMF) exposure significantly boosts the immune response of human neutrophils—our body's first line of defense against infections.
Our Key Discovery
We found that neutrophils, when exposed to LF EMFs, dramatically increase production of neutrophil extracellular traps (NETs)—DNA nets coated with antimicrobial proteins that ensnare and destroy pathogens. This represents a *novel mechanism* by which electromagnetic fields can enhance immune function.
The Science Behind It
Our study identified the NADPH pathway as the critical metabolic process driving this enhancement, revealing a previously unknown interaction between electromagnetic fields and immune cell biology.
Why It Matters
This breakthrough finding suggests that electromagnetic fields can actively modulate immune function, opening new therapeutic possibilities. Our work provides the scientific foundation for developing innovative approaches that leverage this natural mechanism.
-
We've demonstrated that low-frequency electromagnetic fields can directly activate immune cells in the human body.
In our randomized, placebo-controlled crossover study published in Bioelectromagnetics (2022), we showed that exposure to a 5 μT low-frequency electromagnetic field signal for just 30 minutes activates human neutrophils in vivo.
Our Key Discovery
Using a rigorous experimental design, we measured neutrophil granularity in blood samples from healthy volunteers. Our findings confirm that LF-EMF exposure triggers a measurable activation response in these critical immune cells, providing direct evidence of electromagnetic field effects on human immunity.
The Significance
This study marks the first in vivo demonstration that low-intensity electromagnetic fields can modulate human neutrophil activity. Our work establishes a foundation for understanding how electromagnetic fields interact with the immune system in real-world conditions.
Why It Matters
This breakthrough confirms that electromagnetic fields can actively influence immune function in humans, opening new possibilities for therapeutic applications and advancing our understanding of bioelectromagnetic interactions.
-
Flexible, expert advice when you need it. Book hourly support across a range of topics—from planning to problem-solving. This focused consultation will help clarify your goals, map out next steps, and identify opportunities for growth.
-
Planned to achieve after human pilot study to have a safe and effective ImmunoRing.
immunoring clinical study Q4 2026 brainport region
The promise of our R&D is for all early or chronic bacterial and viral infections. Yet, we have decided to focus on Urinary Tract Infections first. rUTI isn’t "just a bladder infection”. It’s a chronic condition for many women with depression rates rivaling other chronic diseases (e.g., diabetes), severe anxiety, and life-altering Quality of Life decline.
We are preparing a clinical study now and ready to empower the medical world with a drug free alternative in treating infections. We’re on a mission to change lives, treating infections with the body’s own immune system instead of anti biotics. Are you a general practitioner, urologist, private clinic owner or investor that believes in doing things differently? Register for our Clinical Study or contact us directly.